AssetMark Inc’s Enfusion, Inc. ENFN Stock Holding History

AssetMark Inc’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-319	Closed	-$4K	–	1711
2022 Q1	$4K	Buy	+319	New	+$4.87K	﹤0.01%	1331

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AssetMark Inc's ENFN Position: Q2 2022 in Review

AssetMark Inc sold out of Enfusion, Inc. (ENFN) in Q2 2022, closing a stake of 319 shares — an estimated $4K sold.

AssetMark Inc first reported a position in ENFN in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 62 funds tracked by Wall St. Rank hold ENFN as of Q2 2022.

AssetMark Inc reported no remaining Enfusion, Inc. position as of Q2 2022 after selling out during the quarter.
AssetMark Inc sold 319 Enfusion, Inc. shares in Q2 2022, an estimated $4K.
AssetMark Inc first reported a position in Enfusion, Inc. in Q1 2022 and held it in 1 quarter.
AssetMark Inc's Enfusion, Inc. position peaked at $4K in Q1 2022.
62 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2022.

Based on AssetMark Inc's 13F filing for Q2 2022, filed 3 Aug 2022.